Fractyl Health Inc (GUTS) FinancialsGUTSFinancialFractyl Health Inc

In the context of the broader market, GUTS competes directly with industry leaders such as COYA and ONCY. With a market capitalization of $104.90M, it holds a significant position in the sector. When comparing efficiency, GUTS's gross margin of N/A stands against COYA's 100.00% and ONCY's N/A. Such benchmarking helps identify whether Fractyl Health, Inc. is trading at a premium or discount relative to its financial performance.

Fractyl Health has shown poor financial performance with a net income loss of $25,538,000 in Q2 2026 and a gross margin of 0% in recent quarters. The company has not generated significant revenue since Q3 2024, indicating ongoing operational challenges.